Action of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines

Oncology Letters

Volumn 12, Issue 3, 2016, Pages 2133-2138

  Mari, Emanuela ^a   Zicari, Alessandra ^a   Fico, Flavia ^a   Massimi, Isabella ^a   Martina, Lolli ^a   Mardente, Stefania ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

AKT signaling; Cluster miR 221 222; High mobility group box 1; MYCN; Neuroblastoma; Phosphatase and tensin homolog

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MICRORNA 221; MICRORNA 222; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOFLUOROMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84979695512     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4876     Document Type: Article

References (27)

1. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007.
2. Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK and DuBois SG: Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer 122: 935-945, 2016.
3. Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, et al: Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol 33: 3008-3017, 2015.
4. Rubie H, De Bernardi B, Gerrard M et al. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol (29): 449-455, 2011
5. Wagner LM, Danks MK. New therapeutic targets for the treatment of high-risk neuroblastoma. J Cell Biochem (107): 46-57, 2009
6. Wang L, Che XJ, Wang N, Li J and Zhu MH: Regulatory network analysis of microRNAs and genes in neuroblastoma. Asian Pac J Cancer Prev 15: 7645-7652, 2014.
7. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, London WB, Chang CH and Yu AL: MicroRNA signature and expression of dicer and drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 70: 7841-7850, 2010.
8. Cui C, Yu J, Huang S, Zhu H and Huang Z: Transcriptional regulation of gene expression by micro RNAs endogenous decoys of transcription factors. Cell Physiol Biochem 33: 1698-1714, 2010
9. Mei H, Lin ZY and Tong QS: The roles of microRNAs in neuroblastoma. World J Pediatr 10: 10-16, 2010.
10. Samaraweera L, Grandinetti KB, Huang R, Spengler BA and Ross RA: MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity. BMC Cancer 14: 309, 2014.
11. Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, et al: MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer 122: 699-704, 2008.
12. Thomas SK, Messam CA, Spengler BA, Biedler JL and Ross RA: Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 279: 27994-27999, 2004.
13. Rothermund K, Rogulski K, Fernandes E, Whiting A, Sedivy J, Pu L and Prochownik EV: C-Myc-independent restoration of multiple phenotypes by two C-Myc target genes with overlapping functions. Cancer Res 65: 2097-2107, 2005.
14. Armstrong MB, Mody RJ, Ellis DC, Hill AB, Erichsen DA and Wechsler DS: N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma. Neoplasia 15: 1363-1370, 2013.
15. Liu Y and Song L: HMGB1-induced autophagy in Schwann cells promotes neuroblastoma proliferation. Int J Clin Exp Pathol 8: 504-510, 2015.
16. Mardente S, Mari E, Massimi I, Fico F, Faggioni A, Pulcinelli F, Antonaci A and Zicari A: HMGB1-induced cross talk between PTEN and miRs 221/222 in thyroid cancer. Biomed Res Int 2015: 512027, 2015.
17. Ayers D, Mestdagh P, Van Maerken T and Vandesompele J: Identification of miRNAs contributing to neuroblastoma chemo-resistance. Comput Struct Biotechnol J 13: 307-319, 2015.
18. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
19. Qiao L, Paul P, Lee S, Qiao J, Wang Y and Chung DH: Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells. Biochem Biophys Res Commun 435: 295-299, 2013.
20. Guglielmi L, Cinnella C, Nardella M, Maresca G, Valentini A, Mercanti D, Felsani A and D'Agnano I: MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells. Cell Death Dis 5: e1081, 2014.
21. Li W, Guo F, Wang P, Hong S and Zhang C: miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status. Curr Mol Med 14: 185-195, 2014.
22. Mardente S, Mari E, Consorti F, Di Gioia C, Negri R, Etna M, Zicari A and Antonaci A: HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncol Rep 28: 2285-2289, 2012.
23. Zhao Z, Ma X, Hsiao THM, Lin G, Kosti A, Yu X, Suresh U, Chen Y, Tomlinson GE, Pertsemlidis A and Du L: A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation. Oncotarget 15: 2499-2512, 2014.
24. Schmidt AM, Yan SD, Yan SF and Stern DM: The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498: 99-111, 2000.
25. Sajithlal G, Huttunen H, Rauvala H and Munch G: Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells. J Biol Chem 277: 6888-6897, 2002.
26. Chen J, Song M, Yu S, Gao P, Yu Y, Wang H and Huang L: Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress. Mol Cell Biochem 335: 137-146, 2010.
27. Wang L, Li S and Jungalwala FB: Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth. J Neuroscience Res 86: 1254-1266, 2010.